Business
Directors' Shareholdings
Directors' Shareholdings.
About this update from Advanced Medical Solutions Group Plc
[{"type":"text","content":"\n \nRNS Number : 1361X Advanced Medical Solutions Grp PLC 04 May 2016 \n\n4 May 2016\nAdvanced Medical Solutions Group plc\n(\"AMS\" or the \"Group\")\n \nDirectors' Shareholdings\n \nWinsford, UK: Advanced Medical Solutions Group plc (AIM: AMS), a leading developer and manufacturer of advanced products for the global surgical and wound care markets, announces that the Trust which manages the Deferred Share Bonus Plan on behalf of the employees of AMS has purchased ordinary shares of 5 pence each (\"Ordinary Shares\") on 3 May 2016, at a price of 183 pence per share on behalf of Chris Meredith and Mary Tavener as part of the Deferred Share Bonus Plan and, under the terms of the Plan, these shares will be held in trust on their behalf.\n \nFollowing these transactions the beneficial ownership of Chris Meredith and Mary Tavener is as follows:\n \n\n\n\n\nDirector\n\n\nDate purchased\n\n\nShares purchased\n\n\nResultant holding\n\n\n% of issued share capital\n\n\n\n\nChris Meredith\nChief Executive Officer\n\n\n3 May 2016\n\n\n2,431\n\n\n1,190,322\n\n\n0.6\n\n\n\n\nMary Tavener\nChief Financial Officer\n\n\n3 May 2016\n\n\n2,431\n\n\n1,828,129\n\n\n0.9\n\n\n\n\n \n \n- Ends -\n \n \nFor further information, please visit www.admedsol.com or contact:\n \n\n\n\n\nAdvanced Medical Solutions Group plc\n\n\nTel: +44 (0) 1606 545508\n\n\n\n\nChris Meredith, Chief Executive Officer\nMary Tavener, Group Finance Director\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nConsilium Strategic Communications\n\n\nTel: +44 (0) 20 3709 5700\n\n\n\n\nMary-Jane Elliott / Jonathan Birt / Matthew Neal / Hendrik Thys \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\nInvestec Bank PLC (NOMAD & Broker)\n\n\nTel: +44 (0) 20 7597 5970\n\n\n\n\nGary Clarence / Daniel Adams / Patrick Robb\n\n\n\n\n\n\n\n \n \nAbout Advanced Medical Solutions Group plc \nAMS is a world-leading independent developer and manufacturer of innovative and technologically advanced products for the global surgical, wound care and wound closure markets, focused on quality outcomes for patients and value for payors. AMS has a wide range of products that include silver alginates, alginates, foams, tissue adhesives, sutures and haemostats, which it markets under its brands; ActivHeal®, LiquiBand® and RESORBA® as well as supplying under...